Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
1.7
-8x
20%
—
-69.45%
40%
—
5 Years
Score1.7
Net Growth-8x
Net Trend20%
Net Income Consistency—
Rev Growth-69.45%
Rev Trend40%
Revenue Consistency—
Arcus Biosciences Inc fundamental performance
Across Arcus Biosciences Inc's full reported history, from 2018 to 2025, revenue grew from $ 8M to $ 247M and net income went from -$ 49M to -$ 353M. Revenue increased in 63% of the years measured; net income in 25%.
Arcus Biosciences Inc currently holds a 5-year HDB Score of 1.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 28.96 | — |
1 Year2025-08-12 | $ 9.67 | 199.48% |
5 Years2021-08-12 | $ 27.78 | 4.25% |
All Time2018-03-15 | $ 17.00 | 70.35% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-03-15 |
|---|---|---|---|---|
| Price | $ 28.96 | $ 9.67 | $ 27.78 | $ 17.00 |
| Return | — | 199.48% | 4.25% | 70.35% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 117M | -$ 452M | $ 702M |
| 2025 | $ 247M | -$ 353M | $ 981M |
| 2024 | $ 258M | -$ 283M | $ 978M |
| 2023 | $ 117M | -$ 307M | $ 759M |
| 2022 | $ 112M | -$ 267M | $ 1.00B |
| 2021 | $ 383M | $ 53M | $ 499M |
| 2020 | $ 78M | -$ 123M | $ 728M |
| 2019 | $ 15M | -$ 75M | $ 188M |
| IPO2018 | $ 8M | -$ 49M | $ 256M |
Explore beyond RCUS
You're looking at Arcus Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
